News
Campus Biotech: At the heart of networked innovation
A shared perspective on two podcast episodes at the heart of Geneva’s scientific life. How can academic research, technological innovation, entrepreneurship, and patient impact come together and speak the same language?Through the first two episodes of the Where Science Talks podcast, Campus Biotech gives voice to the people shaping a vibrant and interconnected…
Read MoreWho You Inherit From Matters: New Genetic Study Uncovers Parent-Specific Effects
A groundbreaking study led by the SIB Statistical Genetics Group (University of Lausanne and Unisanté) reveals that the same genetic variant can affect traits like height, metabolism, and disease risk differently depending on whether it’s inherited from the mother or father. Using a new computational method, researchers analyzed DNA from over 236,000 individuals across…
Read MoreThe Origin of Astrocytes Revealed
A major discovery in neuroscience: a study from the Faculty of Medicine (FacMed) and the Synapsy Center at the University of Geneva uncovers that cortical astrocytes originate from two distinct progenitor cell types. Long considered a uniform support cell population, astrocytes are now recognized as diverse and essential players in brain function, involved in…
Read MoreNovochizol’s AgrINovo Partnership: Swiss-Indian Alliance for Agricultural Innovation
Indian company Aquagri, its partner, and Novochizol SA, a Valais-based startup, announced the launch of AgrINovo, a transformative collaborative project. AgrINovo aims to unlock the full potential of Novochizol technology to foster a healthier, more sustainable agriculture in India and worldwide. Novochizol™ is derived from chitosan, made from chitin, the second most abundant polysaccharide…
Read MoreSwiss Health Valley Biotechs Advance Drug Pipelines with Promising Clinical Milestones
Three innovative biotech companies based in Western Switzerland, Stalicla, Legacy Healthcare and iOnctura, have recently achieved significant progress in their therapeutic pipelines, reinforcing the region’s position as a hub for health innovation. STALICLA: Advancing Precision Medicine for Autism Geneva-based STALICLA has received the green light from the U.S. Food and Drug Administration (FDA) to initiate…
Read MoreRelief Therapeutics is preparing a reverse merger with NeuroX, the successor to MindMaze
The merger must take the form of an exchange of all NeuroX shares for newly issued shares in Relief. The transaction, which is expected to be finalised before the end of the year, would value the Geneva-based company at CHF 100 million and its future partner at CHF 1 billion. The Geneva-based pharmaceutical company…
Read MoreAzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme
Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics. AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…
Read MoreBreaking Through Cancer’s Soft Defense: A Revolutionary Swiss Approach
Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by targeting cancer cells’ physical properties rather than their biology. The project received a CHF 1,4 million grant from Foundation Leenaards. “Our approach targets the mechanical properties of cancer cells by making their membranes stiffer,…
Read Moreplanetary Switzerland: Scaling Mycoprotein Production Through Strategic Expansion
Geneva-based biomanufacturing platform planetary is making significant strides in the alternative protein sector through a combination of strategic acquisitions, IP breakthroughs, retail partnerships, and government-backed expansion plans. The company has positioned itself as continental Europe’s only viable industrial mycoprotein producer, leveraging cutting-edge fermentation technology to create sustainable protein alternatives. Strategic Acquisition of Libre Foods…
Read MoreTwo UNIGE researchers receive ERC grants
Prof. Pedro Herrera and Prof. Giuseppe Iacobucci both receive €150,000 in funding from the European Research Council (ERC) The European Research Council (ERC) announced the first group of researchers who will receive ERC Proof of Concept Grants in 2025. Two scientists from UNIGE are among those selected. Pedro Herrera, Professor in the Department of…
Read More